Refine by
Covid 19 Testing Articles & Analysis
101 news found
In the past year miDiagnostics has been working on the development of an ultra-fast PCR test based on imec technology, to detect COVID-19, with a test result in less than 15 minutes. ...
“We are committed to continuing to find ways to expand testing innovations and solutions as we continue to fight COVID-19,” said Governor Charlie Baker. ...
Founded in 2020 in response to the COVID-19 pandemic, Virusight, which is an AI software company, was created to develop an accurate, real-time virus diagnosis solution. ...
At a study in Philadelphia, one customer told me they had to take several buses to reach the nearest blood-testing lab, a 50-minute trip one-way. Another told me she once waited hours for a blood test at a local hospital. ...
The CE Certificate is quality proof that Reetoo’s COVID-19 self-test kit is well-qualified to be applied in the global market. Many countries have encouraged self-administered antigen tests to screen for infection due to the resurgence of COVID-19. Reetoo's product is capable of facing ...
The COVID-19, pandemic amongst other changes in our lifestyle, has introduced us to new medical terms that we are not quite familiar with, such as the term PCR (polymerase chain reaction). ...
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. ...
Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces the launch of its new B2C e-commerce website, abingdonsimplytest.com. ...
The Virusight solution demonstrated an overall sensitivity of 92.7% (positive percent agreement) and specificity of 96.8% (negative percent agreement) as compared to an EC marked RT-PCR and was shown to be a safe and reliable test for the detection of SARS-CoV-2 antigens and/or virus particles in oral swab samples, providing diagnosis of active ...
Prior to 2020 and the COVID-19 pandemic, the market for disposable medical supplies in Panama steadily grew at an average rate of 10% over the last decade, due to the growing population and increased public and private investment in the health sector. ...
With the launch of its first product, miDiagnostics enters the commercial phase, marking an important milestone in the company’s development. Ultra-fast and reliable COVID testing on a micro-chip miDiagnostics’ COVID-19 PCR Test is based on unique silicon chip technology from imec (Leuven, Belgium) ...
COVID-19 and seasonal allergies have many of the same signs and symptoms. ...
The growth was particularly strong in oncology with 42% higher cartridge revenue compared to Q1 2021, whereas the revenue contribution for COVID-19 testing expectedly reduced by half year-on-year. The gross margin on product sales increased to 34.6%, a solid step-up from 16% in 2021. ...
“In light of the effectiveness and widespread use of available vaccines, the reduction in mortality and the decline in COVID-19 hospitalization rates in the United States, we will continue to evaluate the next steps for this program. ...
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel ...
This year we aim to launch our first ultra-rapid COVID-19 test products, followed by additional in-vitro diagnostic panels, including inflammation, triage, and hormone tests; as we begin to realize our vision of decentralizing diagnostic ...
Thanks to the support from the Health Innovation Hub Ireland, HiberGene were able to work with Bon Secours Health System Ireland, Cork in carrying out a very successful clinical evaluation of its PCR Adapt Covid-19 test, with excellent results. Clinical Need The Gold Standard diagnostic for COVID-19 is a RT- ...
This financing will enable Visby Medical to scale production capacity from tens to hundreds of thousands of tests per month, further expand the product menu to include COVID + influenza A/B combination testing, antimicrobial resistance panels, and deliver the power of PCR diagnostics to consumers at-home. ...
Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its DETECTR BOOST® SARS-CoV-2 Reagent Kit, a first of its kind high-throughput solution that combines the power of CRISPR with laboratory automation for SARS-CoV-2 testing. The DETECTR BOOST platform is a turnkey, CRISPR-based molecular diagnostic system that enables high-throughput, ...
Food and Drug Administration (FDA) recently granted a landmark clearance for the use of the MeMed BV® test on the point-of-need platform MeMed Key®, to help healthcare providers distinguish between bacterial and viral infections in both children and adults. MeMed has also developed the MeMed COVID-19 Severity™ test ...
ByMeMed